CD34 and focal segmental glomerulosclerosis: Injection of whole PBMC – but not CD34-depleted PBMC – derived from patients with recurrent FSGS into humanized NSG mice resulted in Gr-1low myeloid cell expansion in the BM, higher suPAR levels and development of proteinuria, suggesting that FSGS might be considered a hematopoietic stem cell disorder.